Ouverture de l’iTunes Store en cours…Si iTunes ne s’ouvre pas, cliquez sur l’icône de l’application iTunes dans votre Dock Mac ou sur votre bureau Windows.Progress Indicator
Ouverture de l’iBooks Store.Si iBooks ne s’ouvre pas, cliquez sur l’app iBooks dans votre Dock.Progress Indicator

iTunes is the world's easiest way to organize and add to your digital media collection.

iTunes est introuvable sur votre ordinateur. Pour télécharger et vous abonner à « neuroscienceCME - Schizophrenia: Treating a Chronic Disease with a Focus on Early Intervention, Adherence, and Recovery » par CME Outfitters, téléchargez iTunes dès maintenant.

Vous avez déjà iTunes ? Cliquez sur « J’ai déjà iTunes » pour l’ouvrir dès maintenant.

I Have iTunes Téléchargement gratuit
iTunes pour Mac et PC

neuroscienceCME - Schizophrenia: Treating a Chronic Disease with a Focus on Early Intervention, Adherence, and Recovery

By CME Outfitters

Pour écouter un podcast audio, pointez votre souris sur le titre souhaité et cliquez sur l’icône Lecture. Ouvrez iTunes pour télécharger des podcasts et vous y abonner.


Schizophrenia is notable for its substantial impact on everyday functioning, being one of the top five causes of disability in individuals under the age of 25. In most cases, individuals who develop schizophrenia manifest behavioral changes prior to the formal diagnosis of the condition. These changes, referred to as the "prodrome," are variable across individuals who may eventually develop schizophrenia. Proactive risk assessment in other chronic diseases such as cardiovascular disease, diabetes mellitus, and cancer has brought about advances in early detection and intervention leading to substantial reductions in morbidity, mortality, and improved quality of life. It is imperative that this type of proactive intervention becomes part of timely diagnosis and better outcomes for patients with schizophrenia. Clinicians face challenges designing treatment plans for patients with schizophrenia that will maximize adherence and reduce side effects. Relapse rates tend to be quite predictable, can be affected by adherence, and have multiple adverse consequences. Minimizing relapse requires a coordinated effort between the patient, provider, family, and multidisciplinary treatment team. In this interactive neuroscienceCME activity, faculty will focus on the impact of treatment selection, phase of illness, medication adherence, and side effect burden on the journey toward remission and recovery in schizophrenia. This activity also includes a special "After the Show" segment during which the faculty answers additional audience questions in an informal Q&A session.